arotinolol has been researched along with labetalol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, T; Kinjo, N; Moromizato, H; Noguchi, K; Sakanashi, M | 1 |
| Hara, Y; Maniwa, T; Miyagishi, A; Noguchi, T | 1 |
| Chin, WP; Imai, S; Nakagawa, Y; Nakahara, H | 1 |
| Imai, S; Nakahara, H; Nakazawa, M; Takeda, K | 1 |
| Honda, K; Inagaki, O; Nakagawa, C; Shibasaki, M; Sudoh, K | 1 |
| Kinami, J; Maruyama, K; Nagatomo, T; Sasaki, K; Tsuchihashi, H | 1 |
| Abdine, H; Belal, F; Hefnawy, MM; Sultan, MA | 1 |
7 other study(ies) available for arotinolol and labetalol
| Article | Year |
|---|---|
Comparative effects of arotinolol, labetalol and propranolol on regional myocardial dysfunction induced by flow-limiting coronary stenosis in anesthetized dogs.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Blood Pressure; Cardiomyopathies; Coronary Vessels; Dogs; Female; Heart Rate; Hemodynamics; Isoproterenol; Labetalol; Male; Myocardial Contraction; Phenylephrine; Propanolamines; Propranolol | 1990 |
Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain; Cerebrovascular Disorders; Disease Susceptibility; Hypertension; Labetalol; Male; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium, Dietary | 1991 |
Alpha-blockade and vasodilatation induced by nipradilol, arotinolol and labetalol in pithed rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Clonidine; Decerebrate State; Labetalol; Male; Phenylephrine; Prazosin; Propanolamines; Rats; Rats, Inbred Strains; Vasodilation; Yohimbine | 1985 |
Role of the alpha-adrenergic blocking effect in the acute hypotensive effect of beta-adrenergic blocking drugs with alpha-blocking activities in conscious SHR.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Hydralazine; Labetalol; Male; Prazosin; Propanolamines; Rats; Rats, Inbred SHR; Time Factors | 1985 |
Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Decerebrate State; Desoxycorticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanolamines; Heart Rate; Hypertension; Hypertension, Renal; Labetalol; Male; Propanolamines; Rats; Rats, Inbred SHR | 1994 |
Nipradilol displays a unique pharmacological profile of affinities for the different alpha 1-adrenoceptor subtypes.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Ethanolamines; Guinea Pigs; In Vitro Techniques; Isomerism; Labetalol; Male; Prazosin; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha | 1993 |
Spectrofluorometric determination of some beta-blockers in tablets and human plasma using 9,10-dimethoxyanthracene-2-sodium sulfonate.
Topics: Adrenergic beta-Antagonists; Anthracenes; Atenolol; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Labetalol; Propanolamines; Reference Standards; Spectrometry, Fluorescence; Tablets | 2005 |